DRAXIS Health
DRAXIS Health was a Canadian pharmaceutical manufacturer founded in 1987 in Mississauga, producing sterile products, non-sterile products, and radiopharmaceuticals. The corporate domain is currently parked, and no current operational data is available.
- Company typePrivate
- Founded1987
- HeadquartersMississauga, Canada
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
DRAXIS Health firmographics
Firmographics- Name
- DRAXIS Health
- Website
- https://draxis.com
- Company type
- Private
- Founded year
- 1987
- Operating status
- Closed
- Headcount range
- 251–500 employees
- Short description
- DRAXIS Health was a Canadian pharmaceutical manufacturer founded in 1987 in Mississauga, producing sterile products, non-sterile products, and radiopharmaceuticals. The corporate domain is currently parked, and no current operational data is available.
- Ownership category
- akta.pro rank
Where DRAXIS Health is headquartered
LocationHeadquarters
- HQ city
- Mississauga
- HQ country
- Canada
- HQ region
- North America
Markets served
DRAXIS Health business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales
DRAXIS Health product offering
Product offeringCore offering
DRAXIS Health manufactures and distributes pharmaceutical products organized in three categories: sterile products (injectables), non-sterile products (oral/topical forms), and radiopharmaceuticals used in nuclear medicine diagnostics and therapy. The company operates as a regulated pharmaceutical manufacturer based in Mississauga, Canada, supplying healthcare institutions and distribution channels.
Differentiator
Problem solved
Functional benefit
Products and services
- Sterile Products Sterile pharmaceutical products (e.g., injectables) manufactured under GMP for institutional healthcare buyers.
- Non-Sterile Products Non-sterile pharmaceutical dosage forms (oral, topical, or other non-sterile formats) for institutional healthcare buyers.
- Radiopharmaceuticals Radiopharmaceutical products for nuclear medicine diagnostics and therapy, requiring specialized handling and regulatory compliance.
Companies that use DRAXIS Health
Customer profileIdeal customer profiles1 record
DRAXIS Health technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
DRAXIS Health competitors and assessment
Company assessmentDirect peers
- Lantheus Holdings: U.S. specialty radiopharmaceutical company focused on diagnostic and therapeutic radiopharmaceuticals, directly comparable to DRAXIS's radiopharmaceuticals product line.
- Curium Pharma: Global radiopharmaceutical manufacturer supplying diagnostic and therapeutic nuclear medicine products; comparable to DRAXIS's radiopharmaceuticals capability.
Emerging players
- PCI Pharma Services: Contract pharmaceutical services provider with sterile and non-sterile manufacturing capabilities; comparable to DRAXIS's contract manufacturing profile across sterile and non-sterile categories.
Broad incumbents
- Cardinal Health (Nuclear & Precision Health Solutions): Large healthcare distributor with a dedicated radiopharmacy network manufacturing and distributing radiopharmaceuticals; overlaps with DRAXIS's sterile and radiopharma operations.
- Jubilant Pharmova: Indian-headquartered specialty pharmaceutical manufacturer that acquired the historical DRAXIS Health business; operates sterile injectables, radiopharmaceuticals, and contract manufacturing comparable to DRAXIS's three categories.
- Patheon (Thermo Fisher Scientific – Pharma Services): Contract development and manufacturing organization producing sterile injectables and pharmaceutical preparations, comparable to DRAXIS's sterile and non-sterile manufacturing business.
- Bayer (Radiology / Curium JV heritage): Historically operated a major radiopharmaceuticals business and remains active in imaging agents; comparable to DRAXIS's radiopharmaceuticals category.
- Catalent: Global contract manufacturer of sterile injectables, softgels, and other dosage forms, comparable to DRAXIS's sterile and non-sterile pharmaceutical product lines.
- Hospira (Pfizer CenterOne): Specialty sterile injectable manufacturer (now part of Pfizer's contract manufacturing); closely comparable to DRAXIS's sterile products category.
- GE HealthCare (PDx / radiopharma): Manufactures and distributes diagnostic imaging agents including radiopharmaceuticals, directly comparable to DRAXIS's radiopharma offering.
Market position
Customer concentration
DRAXIS Health social profiles
Digital presenceDRAXIS Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
DRAXIS Health leadership team
Management profileNumber of profiles
DRAXIS Health funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DRAXIS Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DRAXIS Health
What does DRAXIS Health do?
DRAXIS Health manufactures and distributes pharmaceutical products organized in three categories: sterile products (injectables), non-sterile products (oral/topical forms), and radiopharmaceuticals used in nuclear medicine diagnostics and therapy. The company operates as a regulated pharmaceutical manufacturer based in Mississauga, Canada, supplying healthcare institutions and distribution channels.
Is DRAXIS Health a public or private company?
DRAXIS Health is a private company. It is classified as unknown and is currently closed.
When was DRAXIS Health founded?
DRAXIS Health was founded in 1987. It employs 251 to 500 people.
Where is DRAXIS Health based?
DRAXIS Health is headquartered in Mississauga, Canada, in the North America region.
Who are DRAXIS Health's main competitors?
Direct peers on record are Lantheus Holdings and Curium Pharma. PCI Pharma Services is listed as an emerging player. Broad incumbents are Cardinal Health (Nuclear & Precision Health Solutions), Jubilant Pharmova, Patheon (Thermo Fisher Scientific – Pharma Services), Bayer (Radiology / Curium JV heritage), Catalent, Hospira (Pfizer CenterOne) and GE HealthCare (PDx / radiopharma).
Does DRAXIS Health have an API?
No public API is recorded for DRAXIS Health.